Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 28:11:579113.
doi: 10.3389/fneur.2020.579113. eCollection 2020.

Exploring Bottom-Up Visual Processing and Visual Hallucinations in Parkinson's Disease With Dementia

Affiliations

Exploring Bottom-Up Visual Processing and Visual Hallucinations in Parkinson's Disease With Dementia

Nicholas Murphy et al. Front Neurol. .

Abstract

Visual hallucinations (VH) are a common symptom of Parkinson's disease with dementia (PDD), affecting up to 65% of cases. Integrative models of their etiology posit that a decline in executive control of the visuo-perceptual system is a primary mechanism of VH generation. The role of bottom-up processing in the manifestation of VH in this condition is still not clear although visual evoked potential (VEP) differences have been associated with VH at an earlier stage of PD. Here we compared the amplitude and latency pattern reversal VEPs in healthy controls (n = 21) and PDD patients (n = 34) with a range of VH severities. PDD patients showed increased N2 latency relative to controls, but no significant differences in VEP measures were found for patients reporting complex VH (CVH) (n = 17) compared to those without VH. Our VEP findings support previous reports of declining visual system physiology in PDD and some evidence of visual system differences between patients with and without VH. However, we did not replicate previous findings of a major relationship s between the integrity of the visual pathway and VH.

Keywords: Lewy body; Parkinson's disease dementia; visual evoked potential; visual hallucination; visual processing.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer DF declared past co-authorship and research collaboration with several of the authors DC, J-PT, PU, MF to the handling Editor.

Figures

Figure 1
Figure 1
Comparison of Control and Patient VEP waveform. PDD, Parkinson's disease dementia; VEP, Visual evoked potential; VEP components - N1, P1, and N2.
Figure 2
Figure 2
Comparison of the visual evoked potential component (N1, P1, and N2) amplitude and latency. Statistical tests: Univariate analysis of variance (ANOVA), df = 52, p–value 2 sided <0.05 significant; PDD, Parkinson's disease dementia; HC, Healthy Controls; CVH, Complex Visual Hallucination; NCVH, No Complex Visual Hallucination; *Post-hoc = CVH>HC, NCVH>HC.

Similar articles

Cited by

  • Risk of Cognitive Impairment in Patients With Parkinson's Disease With Visual Hallucinations and Subjective Cognitive Complaints.
    Santos-García D, de Deus Fonticoba T, Cores Bartolomé C, Feal Painceiras MJ, Paz González JM, Martínez Miró C, Jesús S, Aguilar M, Pastor P, Planellas L, Cosgaya M, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Gómez Mayordomo V, Nogueira V, Puente V, Dotor García-Soto J, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo Padilla F, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Kulisevsky J, Blázquez Estrada M, Seijo M, Rúiz Martínez J, Valero C, Kurtis M, de Fábregues O, González Ardura J, Alonso Redondo R, Ordás C, López Díaz L LM, McAfee D, Martinez-Martin P, Mir P; COPPADIS Study Group. Santos-García D, et al. J Clin Neurol. 2023 Jul;19(4):344-357. doi: 10.3988/jcn.2022.0186. Epub 2023 Jan 2. J Clin Neurol. 2023. PMID: 36647231 Free PMC article.
  • Redefining Non-Motor Symptoms in Parkinson's Disease.
    Peña-Zelayeta L, Delgado-Minjares KM, Villegas-Rojas MM, León-Arcia K, Santiago-Balmaseda A, Andrade-Guerrero J, Pérez-Segura I, Ortega-Robles E, Soto-Rojas LO, Arias-Carrión O. Peña-Zelayeta L, et al. J Pers Med. 2025 Apr 26;15(5):172. doi: 10.3390/jpm15050172. J Pers Med. 2025. PMID: 40423044 Free PMC article. Review.
  • Face Perception and Pareidolia Production in Patients With Parkinson's Disease.
    Göbel N, Möller JC, Hollenstein N, Binder A, Oechsner M, Ide J, Urwyler P, Cazzoli D, Müri RM. Göbel N, et al. Front Neurol. 2021 Aug 3;12:669691. doi: 10.3389/fneur.2021.669691. eCollection 2021. Front Neurol. 2021. PMID: 34413822 Free PMC article.
  • Structural and functional changes in the retina in Parkinson's disease.
    Alves JN, Westner BU, Højlund A, Weil RS, Dalal SS. Alves JN, et al. J Neurol Neurosurg Psychiatry. 2023 Jun;94(6):448-456. doi: 10.1136/jnnp-2022-329342. Epub 2023 Feb 17. J Neurol Neurosurg Psychiatry. 2023. PMID: 36806480 Free PMC article. Review.

References

    1. Biousse V, Skibell BC, Watts RL, Loupe DN, Drews-Botsch C, Newman NJ. Ophthalmologic features of Parkinson's disease. Neurology. (2004) 62:177–80. 10.1212/01.WNL.0000103444.45882.D8 - DOI - PubMed
    1. Davidsdottir S, Cronin-Golomb A, Lee A. Visual and spatial symptoms in Parkinson's disease. Vision Res. (2005) 45:1285–96. 10.1016/j.visres.2004.11.006 - DOI - PubMed
    1. Archibald NK, Clarke MP, Mosimann UP, Burn DJ. The retina in Parkinson's disease. Brain. (2009) 132(Pt. 5):1128–45. 10.1093/brain/awp068 - DOI - PubMed
    1. Urwyler P, Nef T, Killen A, Collerton D, Thomas A, Burn D, et al. . Visual complaints and visual hallucinations in Parkinson's disease. Parkinsonism Relat Disord. (2014) 20:318–22. 10.1016/j.parkreldis.2013.12.009 - DOI - PubMed
    1. Weil RS, Schrag AE, Warren JD, Crutch SJ, Lees AJ, Morris HR. Visual dysfunction in Parkinson's disease. Brain. (2016) 139:2827–43. 10.1093/brain/aww175 - DOI - PMC - PubMed

LinkOut - more resources